PubRank

Deborah McCurdy

Author PubWeight™ 23.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2007 3.32
2 Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A 2009 2.31
3 Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis. J Rheumatol 2012 1.70
4 Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform. Arthritis Rheum 2007 1.50
5 Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum 2009 1.37
6 Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012 1.33
7 Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci U S A 2011 1.30
8 Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol 2003 1.28
9 Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. Arthritis Rheum 2009 1.23
10 Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci U S A 2007 1.13
11 High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum 2009 1.11
12 Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev 2014 1.10
13 Association of IRF5 polymorphisms with activation of the interferon alpha pathway. Ann Rheum Dis 2009 1.02
14 Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis. J Rheumatol 2006 0.92
15 Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol 2014 0.87
16 Defective DNA double-strand break repair in pediatric systemic lupus erythematosus. Arthritis Rheum 2012 0.85
17 Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe). J Rheumatol 2012 0.82
18 Hypertrophic osteoarthropathy in the hepatopulmonary syndrome. J Clin Rheumatol 2008 0.77
19 Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions. J Rheumatol 2012 0.77
20 Etanercept associated optic neuropathy. Clin Experiment Ophthalmol 2007 0.75
21 Childhood systemic lupus erythematosus. Pediatr Ann 2002 0.75